{"id":"W2343330905","doi":"10.1016/j.jval.2015.09.2481","title":"Comparison of Compliance And Discontinuation Rates Among Ms Patients Treated With Fingolimod and Other Disease-Modifying Therapies: A Canadian Retrospective Claims Analysis","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Calgary; Hôpital Notre-Dame; Health Canada; Novartis (Canada)","funders":"","keywords":"Fingolimod; Natalizumab; Discontinuation; Medicine; Teriflunomide; Glatiramer acetate; Internal medicine; Multiple sclerosis; Pharmacy; Physical therapy; Family medicine; Disease; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003670681,0.0001199385,0.0005202655,0.0003291043,0.00009052369,0.00001823097,0.00003625613,0.00002927148,0.000003749461],"category_scores_gemma":[0.0001875163,0.00008871323,0.00002300659,0.0005601146,0.0001897123,0.00006748937,0.00001794495,0.0001211978,2.929102e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003729199,"about_ca_system_score_gemma":0.000198076,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.4805965,"about_ca_topic_score_gemma":0.2039127,"domain_scores_codex":[0.9987097,0.0001702848,0.0002891137,0.0002626471,0.0002923057,0.0002759784],"domain_scores_gemma":[0.9989728,0.00009109066,0.0001562439,0.000159704,0.0001865204,0.0004335968],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002079089,0.0001165058,0.9914247,0.0001288262,0.0001742429,9.137675e-7,0.007004567,0.0003273285,0.000004574856,0.00002027695,0.00002242156,0.0005677015],"study_design_scores_gemma":[0.001762574,0.0004442397,0.9379023,0.0005112069,0.00005345065,8.942602e-8,0.0009864405,0.05822513,0.000009695105,0.00002154043,0.00001186499,0.00007146799],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9975573,0.001007556,0.00003650033,0.0004951775,0.000007544058,0.000729567,0.00007334808,0.00001040785,0.00008255246],"genre_scores_gemma":[0.9994555,0.0001174096,0.0002667242,0.00006027603,0.00001263493,0.00003275396,0.00002863122,0.00001242741,0.00001364049],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2766837,"threshold_uncertainty_score":0.8106138,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1648320629122082,"score_gpt":0.3993700747735055,"score_spread":0.2345380118612973,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}